CIK 0000907654 · Non-accelerated filer<br>Smaller reporting company
Oruka Therapeutics, Inc.
Sign in to watch- Ticker
- ORKA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 363855489
- Phone
- 650-606-7910
- Business address
- 855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
- Former names
- ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $20,653,308
- in 17 filings, $20.2M under 10b5-1 plans
Net −$20,653,308. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Klein Lawrence Otto −$11.6M Chief Executive Officer sold 12% of stake
- Agarwal Arjun −$2.8M Senior Vice President, Finance sold 68% of stake
- Goncalves Joana −$2.0M Chief Medical Officer sold 41% of stake
- BALL KRISTINE M −$1.9M Director sold 100% of stake
- Quinlan Paul T −$1.7M General Counsel sold 40% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-16 | Goncalves Joana Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −3,500 | 214,563 | ||
| 2026-03-16 | Goncalves Joana Chief Medical Officer | Option exercise · Employee Warrant (right to buy) 10b5-1 | −3,500 | 185,992 | ||
| 2026-03-16 | Quinlan Paul T General Counsel | Sale | −733 | $41.30 | $30K | 31,767 |
| 2026-03-02 | Sandler Laura Lee Chief Operating Officer | Option exercise 10b5-1 | +5,000 | $7.80 | $39K | 242,584 |
| 2026-03-02 | Sandler Laura Lee Chief Operating Officer | Sale 10b5-1 | −2,325 | $33.28 | $77K | 240,259 |
| 2026-03-02 | Sandler Laura Lee Chief Operating Officer | Sale 10b5-1 | −2,675 | $33.81 | $90K | 237,584 |
| 2026-03-02 | Sandler Laura Lee Chief Operating Officer | Option exercise · Employee Warrant (right to buy) 10b5-1 | −5,000 | 89,996 | ||
| 2026-02-17 | Goncalves Joana Chief Medical Officer | Option exercise 10b5-1 | +3,500 | $6.84 | $24K | 37,518 |
| 2026-02-17 | Goncalves Joana Chief Medical Officer | Option exercise 10b5-1 | +3,500 | $7.80 | $27K | 41,018 |
| 2026-02-17 | Goncalves Joana Chief Medical Officer | Sale 10b5-1 | −6,064 | $32.30 | $196K | 34,954 |
| 2026-02-17 | Goncalves Joana Chief Medical Officer | Sale 10b5-1 | −936 | $32.78 | $31K | 34,018 |
| 2026-02-17 | Goncalves Joana Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −3,500 | 218,063 | ||
| 2026-02-17 | Goncalves Joana Chief Medical Officer | Option exercise · Employee Warrant (right to buy) 10b5-1 | −3,500 | 189,492 | ||
| 2026-01-23 | Goncalves Joana Chief Medical Officer | Grant or award | +32,500 | 34,018 | ||
| 2026-01-23 | Goncalves Joana Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +130,000 | 130,000 | ||
| 2026-01-23 | Sandler Laura Lee Chief Operating Officer | Grant or award | +32,500 | 237,584 | ||
| 2026-01-23 | Sandler Laura Lee Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +130,000 | 130,000 | ||
| 2026-01-23 | Agarwal Arjun SVP, Finance | Grant or award | +17,500 | 19,258 | ||
| 2026-01-23 | Agarwal Arjun SVP, Finance | Grant or award · Employee Stock Option (right to buy) | +70,000 | 70,000 | ||
| 2026-01-23 | Klein Lawrence Otto Chief Executive Officer | Grant or award | +76,700 | 929,038 |
Page 12 of 18 · 346 trades